Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer
Clinical trial NCT03121352 · COMPLETED
Trial details
- NCT number
- NCT03121352
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-19
- Primary completion
- 2022-02-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.